Prevention and treatment of hypertensive left ventricular hypertrophy

被引：0
作者：
Tatavarthy, Manvita [1 ]
Stathopoulos, John [1 ]
Oktay, Ahmet Afsin [2 ,3 ]
机构：
[1] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Div Cardiol, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Med, Div Cardiol, 1717W Congress Pkwy,Kellogg 316, Chicago, IL 60612 USA
来源：
CURRENT OPINION IN CARDIOLOGY | 2024年 / 39卷 / 04期
关键词：
antihypertensives; ECG; echocardiography; hypertension; left ventricular hypertrophy; PRESERVED EJECTION FRACTION; BLOOD-PRESSURE; HEART-FAILURE; PROGNOSTIC IMPLICATIONS; EUROPEAN-SOCIETY; DIETARY-SODIUM; MASS; RISK; PREVALENCE; REGRESSION;
D O I：
10.1097/HCO.0000000000001135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose of reviewLeft ventricular (LV) hypertrophy (LVH) is a well recognized target organ adaptation to longstanding uncontrolled hypertension and other cardiovascular risk factors. It is also a strong and independent predictor of many cardiovascular disorders.Recent findingsThis focused review explores the current concepts in screening, diagnosis, prevention, and treatment of LVH in patients with hypertension. Currently, the primary screening and diagnostic tools for LVH are ECG and 2D echocardiography. Implementing machine learning in the diagnostic modalities can improve sensitivity in the detection of LVH. Lifestyle modifications, blood pressure control with antihypertensive therapy, and management of comorbidities aid in preventing and reversing LV remodeling.SummaryLVH is a common and often silent complication of hypertension. Prevention and reversal of LV remodeling are crucial for cardiovascular risk reduction in patients with hypertension.
引用
收藏
页码：251 / 258
页数：8
相关论文
共 68 条
  • [51] Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease
    Saito, Makoto
    Khan, Faisal
    Stoklosa, Ted
    Iannaccone, Andrea
    Negishi, Kazuaki
    Marwick, Thomas H.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2016, 9 (08) : 911 - 921
  • [52] Deep Learning Models for Predicting Left Heart Abnormalities From Single-Lead Electrocardiogram for the Development of Wearable Devices
    Sato, Masataka
    Kodera, Satoshi
    Setoguchi, Naoto
    Tanabe, Kengo
    Kushida, Shunichi
    Kanda, Junji
    Saji, Mike
    Nanasato, Mamoru
    Maki, Hisataka
    Fujita, Hideo
    Kato, Nahoko
    Watanabe, Hiroyuki
    Suzuki, Minami
    Takahashi, Masao
    Sawada, Naoko
    Yamasaki, Masao
    Sawano, Shinnosuke
    Katsushika, Susumu
    Shinohara, Hiroki
    Takeda, Norifumi
    Fujiu, Katsuhito
    Daimon, Masao
    Akazawa, Hiroshi
    Morita, Hiroyuki
    Komuro, Issei
    [J]. CIRCULATION JOURNAL, 2024, 88 (01) : 146 - +
  • [53] The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
    Schmieder, Roland E.
    Wagner, Frank
    Mayr, Michael
    Delles, Christian
    Ott, Christian
    Keicher, Christian
    Hrabak-Paar, Maja
    Heye, Tobias
    Aichner, Solveig
    Khder, Yasser
    Yates, Denise
    Albrecht, Diego
    Langenickel, Thomas
    Freyhardt, Patrick
    Janka, Rolf
    Bremerich, Jens
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3308 - 3317
  • [54] Metabolic surgery in improving arterial health in obese individuals
    Sebastian, Sneha Annie
    Co, Edzel Lorraine
    Kanagala, Sai Gautham
    Padda, Inderbir
    Sethi, Yashendra
    Johal, Gurpreet
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (03)
  • [55] Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension SPRINT (Systolic Blood Pressure Intervention Trial)
    Soliman, Elsayed Z.
    Ambrosius, Walter T.
    Cushman, William C.
    Zhang, Zhu-ming
    Bates, Jeffrey T.
    Neyra, Javier A.
    Carson, Thaddeus Y.
    Tamariz, Leonardo
    Ghazi, Lama
    Cho, Monique E.
    Shapiro, Brian P.
    He, Jiang
    Fine, Lawrence J.
    Lewis, Cora E.
    [J]. CIRCULATION, 2017, 136 (05) : 440 - +
  • [56] Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial
    Soliman, Elsayed Z.
    Byington, Robert P.
    Bigger, J. Thomas
    Evans, Gregory
    Okin, Peter M.
    Goff, David C.
    Chen, Haiying
    [J]. HYPERTENSION, 2015, 66 (06) : 1123 - 1129
  • [57] Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA (Multi-Ethnic Study of Atherosclerosis)
    Sparapani, Rodney
    Dabbouseh, Noura M.
    Gutterman, David
    Zhang, Jun
    Chen, Haiying
    Bluemke, David A.
    Lima, Joao A. C.
    Burke, Gregory L.
    Soliman, Elsayed Z.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (05):
  • [58] Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis
    Tadic, Marijana
    Gherbesi, Elisa
    Sala, Carla
    Carugo, Stefano
    Cuspidi, Cesare
    [J]. JOURNAL OF HYPERTENSION, 2022, 40 (04) : 641 - 647
  • [59] Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain
    Tanaka, Hidekazu
    [J]. JOURNAL OF ECHOCARDIOGRAPHY, 2021, 19 (02) : 71 - 79
  • [60] Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension
    Thürmann, PA
    Kenedi, P
    Schmidt, A
    Harder, S
    Rietbrock, N
    [J]. CIRCULATION, 1998, 98 (19) : 2037 - 2042
1234567